Powder: -20°C for 3 years | In solvent: -80°C for 1 year
UCB-J is a radioligand for the synaptic vesicle protein 2A (SV2A), utilized in positron emission tomography (PET)[4].
Description | UCB-J is a radioligand for the synaptic vesicle protein 2A (SV2A), utilized in positron emission tomography (PET)[4]. |
In vivo | UCB-J demonstrates a significant unbound fraction (0.46 ± 0.02) and undergoes moderate metabolic rates in plasma, with 39% ± 5% and 24% ± 3% of the parent compound remaining after 30 and 90 minutes, respectively[3]. This compound also exhibits substantial uptake and rapid kinetics within the monkey brain[3]. Notably, pretreatment of an animal with UCB-J (150 μg/kg, iv) results in a reduction of the whole brain Standard Uptake Value (SUV) to levels comparable to those of the centrum semiovale, thereby highlighting [18F]7's in vivo binding specificity towards SV2A[4]. |
Molecular Weight | 320.315 |
Formula | C17H15F3N2O |
CAS No. | 1604786-87-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
UCB-J 1604786-87-9 UCB J UCBJ inhibitor inhibit